Table 2.
Parameter | BiOSS group | DES group | ||
---|---|---|---|---|
No ISR | ISR | No ISR | ISR | |
N = 198 (%) | n = 24 (%) | N = 206 (%) | n = 17 (%) | |
MV predilatation | 117 (59.1) | 20 (83.3)∗ | 145 (70.4) | 14 (82.4) |
SB predilatation | 67 (33.8) | 7 (29.2) | 57 (27.7) | 8 (47.1)∗,∗∗ |
Nominal stent diameter [mm] | – | – | 3.34 ± 0.45 | 3.22 ± 0.51 |
Nominal stent diameter in MV [mm] | 3.70 ± 0.33 | 3.72 ± 0.41 | – | – |
Nominal stent diameter in MB [mm] | 3.01 ± 0.34 | 3.00 ± 0.38 | – | – |
Nominal stent length [mm] | 17.44 ± 1.54 | 18.21 ± 2.50 | 20.28 ± 4.32 | 20.53 ± 5.62 |
Sirolimus eluting | 88 (44.4) | 14 (58.3) | 148 (71.8) | 7 (41.2)∗,∗∗ |
Paclitaxel eluting | 110 (55.6) | 10 (41.7) | 58 (28.2) | 10 (58.8)∗,∗∗ |
POT | 81 (40.9) | 2 (8.3)∗ | 152 (73.8) | 1 (5.9)∗ |
FKB | 65 (32.8) | 6 (25) | 101 (49) | 9 (52.9)∗∗ |
stent in SB | 17 (8.6) | 5 (20.8) | 7 (3.4) | 8 (47.1)∗,∗∗ |
∗ P < 0.05 No ISR vs. ISR in BiOSS or rDES groups. ∗∗P < 0.05 ISR between BiOSS and rDES groups. FKB: final kissing balloon; ISR: in-stent restenosis; MB: main branch; MV: main vessel; POT: proximal optimization technique; SB: side branch.